Giripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research[1][2].
Molecular Weight:
745.25
Purity:
99.68
CAS Number:
[865200-20-0]
Formula:
C41H36ClF3N2O4S
Target:
Phospholipase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted